StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$25.39−0.77 (-2.94%)

Close on Nov 19, 2026Market cap $13.14BP/E –Yield 2.05%

Baxter International free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Baxter International's free cash flow for the twelve months ending Dec 31, 2023 was $1.29B, up 55.2% year over year. For fiscal 2025 it was $332.00M, down 42.1% from the year before. Over ten years it grew -9.1% a year on average. The highest annual figure on record is $2.49B in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$332.00M-42.1%
FY2024Dec 31, 2024$573.00M-55.7%
FY2023Dec 31, 2023$1.29B+55.2%
FY2022Dec 31, 2022$834.00M-45.5%
FY2021Dec 31, 2021$1.53B+32.1%
FY2020Dec 31, 2020$1.16B-17.7%
FY2019Dec 31, 2019$1.41B+3.7%
FY2018Dec 31, 2018$1.36B+23.7%
FY2017Dec 31, 2017$1.10B+17.4%
FY2016Dec 31, 2016$935.00M+8.7%
FY2015Dec 31, 2015$860.00M-62.4%
FY2014Dec 31, 2014$2.29B-8.1%
FY2013Dec 31, 2013$2.49B+28.1%
FY2012Dec 31, 2012$1.95B+4.7%
FY2011Dec 31, 2011$1.86B-9.0%
FY2010Dec 31, 2010$2.04B+7.7%
FY2009Dec 31, 2009$1.90B+21.4%
FY2008Dec 31, 2008$1.56B-3.2%
FY2007Dec 31, 2007$1.61B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$601.00M+20.2%
Q3 FY2023Sep 30, 2023$191.00M+48.1%
Q2 FY2023Jun 30, 2023$195.00M+42.3%
Q1 FY2023Mar 31, 2023$307.00M+351.5%
Q4 FY2022Dec 31, 2022$500.00M-2.0%
Q3 FY2022Sep 30, 2022$129.00M-74.0%
Q2 FY2022Jun 30, 2022$137.00M-57.1%
Q1 FY2022Mar 31, 2022$68.00M-67.0%
Q4 FY2021Dec 31, 2021$510.00M+7.4%
Q3 FY2021Sep 30, 2021$496.00M+40.1%
Q2 FY2021Jun 30, 2021$319.00M+38.7%
Q1 FY2021Mar 31, 2021$206.00M+106.0%
Q4 FY2020Dec 31, 2020$475.00M-25.5%
Q3 FY2020Sep 30, 2020$354.00M-33.7%
Q2 FY2020Jun 30, 2020$230.00M-23.6%
Q1 FY2020Mar 31, 2020$100.00M–
Q4 FY2019Dec 31, 2019$638.00M+26.8%
Q3 FY2019Sep 30, 2019$534.00M+63.8%
Q2 FY2019Jun 30, 2019$301.00M+19.9%
Q1 FY2019Mar 31, 2019-$65.00M-123.4%
Q4 FY2018Dec 31, 2018$503.00M+171.9%
Q3 FY2018Sep 30, 2018$326.00M-31.2%
Q2 FY2018Jun 30, 2018$251.00M-32.7%
Q1 FY2018Mar 31, 2018$278.00M+321.2%
Q4 FY2017Dec 31, 2017$185.00M-63.9%
Q3 FY2017Sep 30, 2017$474.00M–
Q2 FY2017Jun 30, 2017$373.00M–
Q1 FY2017Mar 31, 2017$66.00M–
Q4 FY2016Dec 31, 2016$513.00M–

More Baxter International figures

See a number that looks wrong?